Virpax Pharmaceuticals, Inc. - Common Stock (NQ:VRPX)Press Releases about Virpax Pharmaceuticals, Inc. - Common Stock![]() ![]()
Virpax Pharmaceuticals Reports 2022 Third Quarter Results
November 09, 2022
Via Business Wire
![]() ![]() ![]()
Virpax Pursues OTC Medical Device Pathway for AnQlar™
July 05, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Virpax Pharmaceuticals Reports 2021 Year-End Results
March 31, 2022
Via Business Wire
![]() ![]() From Nanomerics Ltd
Via AccessWire
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Business Wire
![]() ![]() ![]() ![]()
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
November 10, 2021
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]()
Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021
September 02, 2021
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|